Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Diabetic retinopathy Stories

2013-09-17 16:23:57

TARRYTOWN, N.Y., Sept. 17, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that detailed results from the Phase 3 VIVID and VISTA trials of EYLEA(®) (aflibercept) Injection in Diabetic Macular Edema (DME) will be presented at an oral session during the upcoming annual meeting of the Retina Society to be held September 26-29 in Los Angeles, United States. These data will be presented on Friday, September 27, at 4:51 PM PDT. Separately, these data...

2013-09-05 04:21:54

LEUVEN, Belgium, September 5, 2013 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR:BR), a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that it has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize novel drugs inhibiting a specific target for the treatment of ophthalmic diseases, such as diabetic macular edema (DME). DME is a leading cause of...

2013-09-04 23:05:05

International Academy of Low Vision Specialists optometrists utilizing new lens technology to help correct a basic problem experienced by those with macular degeneration (ARMD). Corona, CA (PRWEB) September 04, 2013 There is new hope for people whose vision has been compromised by age related macular degeneration (ARMD), glaucoma and diabetic retinopathy. Many patients with these diseases have heard that nothing more can be done for them, but pioneering changes in recent months may offer...

2013-08-31 23:02:43

Patients suffering from diabetic retinopathy learn how to control their diabetes and how to manage their disease at Specialty Retina Center of Boca Raton. The surgeons at Specialty Retina Center expand their reach across South Florida, educating patients on disease prevention. Boca Raton, FL (PRWEB) August 31, 2013 Local surgeons are educating Boca Raton residents on the importance of regular eye exams and the importance of regular check-ups. Patients with diabetes need to be vigilant...

2013-08-31 23:01:38

New Low Vision Website Provides Valuable Resources to Those Suffering with (AMD) Age Related Macular Degeneration and other Vision Limiting Conditions Corona, CA (PRWEB) August 31, 2013 The International Academy Of Low Vision Specialists is pleased to announce the launch of a standalone website, http://www.LowVisionEyeDoctors.com dedicated to educating consumers about low vision and low vision solutions. The site was created to serve as an online resource for people with vision...

2013-08-07 08:30:16

NEW YORK, Aug. 7, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (NasdaqCM: OHRP) today announced the addition of John J. Wroblewski M.D. to its Scientific Advisory Board ("SAB"). The board, comprised of leading retinal ophthalmology experts, advises the company on its clinical programs, regulatory strategy and provides strategic guidance to support the ongoing development of lead drug candidate Squalamine in multiple neovascular ophthalmic clinical indications, each with sizable...

2013-08-06 04:21:15

U.S. and ex-U.S. regulatory submissions in diabetic macular edema expected in 2013; U.S. regulatory submission approximately one year earlier than previously planned TARRYTOWN, N.Y., Aug. 6, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg...

2013-07-24 08:29:45

ASMR level IV opinion is significant step towards commercialization in France of the first and only treatment approved for chronic diabetic macular edema ATLANTA, July 24, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that the Transparency Commission (Commission de la Transparence or CT) of the French...

2013-07-09 16:23:16

West Coast Black Family Reunion Celebration Provides Forum for Eye Health Education, Free Vision Screenings LOS ANGELES, July 9, 2013 /PRNewswire/ -- With recent research confirming an alarming increase in eye disease among older Americans, the National Council of Negro Women (NCNW) and Transitions Optical, Inc. have amplified their efforts to educate at-risk African Americans about the importance of regular eye care. With support from the Transitions Cultural Connections(TM)...

2013-07-09 12:28:38

MORGANTOWN, W. Va., July 9, 2013 /PRNewswire/ -- The Eye Foundation of America, announced today that it has launched its "100,000 Lives" fund-raising campaign with the goal of providing eye care to 100,000 people in rural India during 2014. (Photo: http://photos.prnewswire.com/prnh/20130529/NE22746) The campaign will focus on those who suffer from diabetes and are at risk for, or may already be suffering from diabetic retinopathy -- a condition that often leads to blindness if...